Home » News Articles » Can Hyperbaric Chamber Help Long After COVID?
Covid

Can Hyperbaric Chamber Help Long After COVID?

COVID-19, caused by the SARS COV-2 virus is documented as a pandemic by WHO. The infection may lead to mild or severe respiratory sickness that can be fatal in many cases. To date over 6.5 million deaths have been reported worldwide due to COVID. As the infection belongs to the respiratory system, so respiratory failure causes hypoxic conditions to body tissues. As a result, patients suffer from lethargy, fatigue, lack of energy, breathing problems, and hypoxia. Most patients with severe disease progression need ventilators to breathe pure oxygen instead of normal air. Hyperbaric oxygen chambers, being more efficient than usual ventilators found to be efficient for COVID patients with prolonged symptoms. 

The efficiency of HBOT to treat immediate COVID symptoms

  1. M. Cuerdohe et al. published research on the effectiveness of HBOT for COVID, supported by evidence 4. Hypoxia is the major cause of death among infected people. To save people across the globe, ventilators were used on a large scale. 
  • Restoration of oxyhemoglobin: According to reports, some people face the symptoms for a longer period of time. HBOT is potent therapy to restore oxyhemoglobin, oxygenate tissues, and distribute oxygen and nutrients to body cells.  
  • Anti-inflammatory properties: In addition to the oxygen supply, HBOT exhibits anti-inflammatory properties and helps body tissues repair quickly. It downregulates the pro-inflammatory and inflammatory cytokines and inflammasomes. 

They found that HBOT significantly reduced the mortality rate from 26% in the control group to 12% in the HBOT group. 

 

HBOT long COVID symptoms

Research published in Scientific Reports on July 2022 by an Israeli group provides clinical evidence of HBOT efficacy for prolonged COVID symptoms. Aviv clinic reported that HBOT could potentially relieve the users from long COVID symptoms and help them to perform well. It has been reported that millions of people across the globe are suffering from COVID symptoms after days, weeks, months, or even a year or more after getting infected. If we only talk about the USA, more than 20% of the infected people suffer from these symptoms for as long as three months or even more according to CDC. Likewise, similar reports were documented by UK researchers, providing data on small-scale research. The people complained of long-term symptoms related to brain fog and cognitive instability. Following are the listed symptoms that bother people.

 

  • fatigue
  • fever
  • pain
  • shortness of breath
  • heart palpitations
  • neurological issues
  • indigestion 
  • brain fog
  • depression
  • trouble sleeping
  • headaches
  • anxiety
  • lack of concentration
  • energy deficiency

 

CNS-related post-COVID complications

CNS-associated post-COVID condition is due to injured neurons primarily in the frontal lobe of the brain. The frontal lobe is linked to cognitive function, thinking, and other mental functions that are responsible for controlling various mechanisms for proper body functioning. The director of Sagol Center and chairperson of Aviv Medical Advisory board, Dr. Shai Efrati stated “we can anticipate that in few patients, Corona Virus may penetrate the brain via cribriform plate (skull part adjacent to nose). After successful penetration, the virus damages brain tissue, triggering post-COVID cognitive impairment. HBOT has been found to downregulate inflammatory cytokines, upregulate repair factors, promote tissue regeneration, and relieve the users from CNS-related complications after infection. 

Mechanism of action of HBOT

The mode of action of HBOT in the aforementioned long-term complications is comparable to its efficacy in treating age-related cognitive impairment, post-traumatic stress disorder (PSTD), stroke, brain injuries, and dementia. The primary role of HBOT is an adjuvant therapy to boost neuronal performance through tissue oxygenation, neovascularization, regeneration, damage repair, and stem cell mobilization.  

The market size of hyperbaric chambers post-COVID forecast  

COVID-19 has brought many discrepancies with it, boosting the market value of certain products while lowering others’. Strict lockdowns implemented by different countries have caused a lag in the supply of almost all products worldwide. Hyperbaric Oxygen Therapy Chambers are also among those products for which the import and export drastically got affected. COVID-19 affected the market for various products in three main ways:

  • Directly affecting the production and due to lockdowns and lack of labor force. 
  • Disrupting the market because of supply chain breakage.
  • Financial crises faced by markets and industries.

As far as hyperbaric oxygen chambers are concerned, the year 2021 is regarded as the base year while a five-year time span from 2022 to 2027 is the forecast period for its market impact. It is predicted that over this five-year time span, the Hyperbaric oxygen chamber market will skyrocket due to its increasing popularity, growing research, proven efficiency, user-friendliness, and many other factors.

Oxyhelp

Types of hyperbaric oxygen chambers in market

HBOT chambers’ market in focusing on two kinds of chambers. 

  • Monoplace chambers: They are convenient for people who use them at home. Only a single person gets therapy at a time. 
  • Multiplace chambers: Many people can take therapy at a time. Considering the prevalence of COVID and disease spread, these chambers can be useful to accommodate more people at a time. 

The predicted regions to dominate the HBOT chambers market

The countries where in the next five years the HBOT market size is predicted to expand exponentially include: 

 

Continent Country
North America United States, Mexico, and Canada
Asia-Pacific China, Australia, Indonesia, Thailand, Malaysia, Philippines, and Vietnam
South America Columbia, Brazil, Argentina.
Europe UK, Germany, France, Italy, Russia, Turkey, etc.
Middle East and Africa Saudi Arabia, Egypt, Nigeria, UAE, South Africa

 

Oxyhelp Hyperbaric Oxygen Chambers

Oxyhelp is a European company, which manufactures supreme quality HBOT chambers by assembling the components purchased from the World’s renowned companies based in Spain, the USA, Japan, and Germany. The careful choice of material, innovative design, user-friendly procedures to operate, automated system, antibacterial anterior, and many other features make it a competitive company in global market. The Oxyhelp chambers are safe to use both for therapeutic and personal applications.

Conclusion

HBOT is an effective therapy for post-COVID complications and helps users get rid of fatigue, sleep issues, concentration problems, psychiatric symptoms, and cognitive impairment. It is all because of its ability to promote tissue regeneration, oxygenation, neovascularization, improved blood flow, removal of toxins, and various other physiological benefits. Overall, it stimulates the normal metabolism of the human body and retrieves proper functioning.  

Can Hyperbaric Chamber Help Long After COVID?

Leave a Reply

Your email address will not be published. Required fields are marked *

*

This site uses Akismet to reduce spam. Learn how your comment data is processed.

About KHTS Articles